Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Molecular Profile | PDGFRB R849_D850delinsH |
| Therapy | Dasatinib |
| Indication/Tumor Type | Advanced Solid Tumor |
| Response Type | predicted - sensitive |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| PDGFRB R849_D850delinsH | Advanced Solid Tumor | predicted - sensitive | Dasatinib | Preclinical - Biochemical | Actionable | In a preclinical study, Sprycel (dasatinib) treatment inhibited Pdgfrb activity in a reporter assay in a cell line expressing PDGFRB R849_D850delinsH (PMID: 39580648). | 39580648 |
| PubMed Id | Reference Title | Details |
|---|---|---|
| (39580648) | A germline PDGFRB splice site variant associated with infantile myofibromatosis and resistance to imatinib. | Full reference... |